Literature DB >> 8995659

Marek's disease virus latency-associated transcripts belong to a family of spliced RNAs that are antisense to the ICP4 homolog gene.

J L Cantello1, M S Parcells, A S Anderson, R W Morgan.   

Abstract

Marek's disease virus (MDV) latency-associated transcripts include at least two MDV small RNAs (MSRs) and a 10-kb RNA which map antisense to the ICP4 homolog gene and are relatively abundant in MDV-transformed lymphoblastoid cells. This report further describes the biological and structural properties of these RNAs. First, these RNAs were detected in primary lymphomas isolated from chickens infected with several oncogenic MDV strains. Second, the MSRs are nonpolyadenylated, whereas, the 10-kb RNA is predominantly polyadenylated. Third, MSRs localize to the nuclei of both lymphoblastoid cells and cytolytically infected chicken embryo fibroblasts. Fourth, the 3'-region splice junctions of the MSRs during latent and productive infection were determined by sequencing RNA-PCR products generated with primers that flank the 3' splice region. The MSRs contain at least three introns, the largest of which overlaps the ICP4 putative translational start site. Fifth, the 5' end of the MSRs initiates approximately 5 kb upstream from the main body of the RNA. The extreme 5' exon is approximately 251 nucleotides (nt) long and is joined to the main body of the transcript upon removal of a 4,852-nt intron. Finally, the 10-kb RNA lies entirely within the repeats flanking the unique short region of the genome. We believe that the MSRs and 10-kb RNA belong to a family of spliced RNAs that map antisense to the ICP4 gene and comprise a complex transcriptional unit expressed during MDV-induced T-cell transformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995659      PMCID: PMC191190     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  Transcription termination and 3' processing: the end is in site!

Authors:  M L Birnstiel; M Busslinger; K Strub
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

Review 2.  Marek's disease--a model for herpesvirus oncology.

Authors:  B W Calnek
Journal:  Crit Rev Microbiol       Date:  1986       Impact factor: 7.624

3.  The regulation of synthesis and properties of the protein product of open reading frame P of the herpes simplex virus 1 genome.

Authors:  M Lagunoff; B Roizman
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

4.  Inverted repeat nucleotide sequences in the genomes of Marek disease virus and the herpesvirus of the turkey.

Authors:  J Cebrian; C Kaschka-Dierich; N Berthelot; P Sheldrick
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

5.  Structure of Marek's disease virus DNA: detailed restriction enzyme map.

Authors:  K Fukuchi; M Sudo; Y S Lee; A Tanaka; M Nonoyama
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

6.  Detection of bovine herpesvirus type 1 RNA in trigeminal ganglia of latently infected rabbits by in situ hybridization.

Authors:  D L Rock; W A Hagemoser; F A Osorio; D E Reed
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

7.  The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes.

Authors:  P Brunovskis; L F Velicer
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

8.  Proteins and cis-acting elements associated with transactivation of the varicella-zoster virus (VZV) immediate-early gene 62 promoter by VZV open reading frame 10 protein.

Authors:  H Moriuchi; M Moriuchi; J I Cohen
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells.

Authors:  W R Shek; B W Calnek; K A Schat; C H Chen
Journal:  J Natl Cancer Inst       Date:  1983-03       Impact factor: 13.506

10.  Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes.

Authors:  M S Parcells; A S Anderson; T W Morgan
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  20 in total

1.  Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys.

Authors:  T Yamaguchi; S L Kaplan; P Wakenell; K A Schat
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  The genome of a very virulent Marek's disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Characterization of a Gallid herpesvirus 2 strain with novel reticuloendotheliosis virus long terminal repeat inserts.

Authors:  Yan-Ping Zhang; Ke-Yan Bao; Guo-Rong Sun; Hong-Chao Lv; Hong-Yu Cui; Yu-Long Gao; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Virus Genes       Date:  2017-02-13       Impact factor: 2.332

4.  Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.

Authors:  M S Parcells; R L Dienglewicz; A S Anderson; R W Morgan
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus.

Authors:  S H Chen; M F Kramer; P A Schaffer; D M Coen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Genome sequence determination and analysis of a Chinese virulent strain, LMS, of Gallid herpesvirus type 2.

Authors:  Yun Cheng; Feng Cong; Yan-ping Zhang; Zhi-jie Li; Na-na Xu; Guang-yu Hou; Chang-Jun Liu
Journal:  Virus Genes       Date:  2012-04-04       Impact factor: 2.332

7.  Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript.

Authors:  Joan Burnside; Erin Bernberg; Amy Anderson; Cheng Lu; Blake C Meyers; Pamela J Green; Neeta Jain; Grace Isaacs; Robin W Morgan
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus.

Authors:  Mariana Bego; J Maciejewski; S Khaiboullina; G Pari; S St Jeor
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.

Authors:  E Le Rouzic; P Thoraval; M Afanassieff; Y Cherel; G Dambrine; B Perbal
Journal:  Mol Pathol       Date:  2002-08

10.  Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4.

Authors:  Keith William Jarosinski; Priscilla Helene O'Connell; Karel Antoni Schat
Journal:  Virus Genes       Date:  2003-05       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.